Recruitment as Scientific Writing Project Specialist at Novartis

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Opportunity for M.Pharm, M.Sc as Assistant Manager at Sanofi

Vacancy for D.Pharm, B.Pharm as Key Accounts Specialist at Baxter

Pharmacist Hero Vol 4

PharmaTutor facilitating these Pharmacy warriors who are contributing against fight of COVID-19. This is Volume 4. We shall keep posting list of more Pharmacist Heroes.

Any pharmacist from industry, academics, researcher or community pharmacist who contributing actively for fight aganist COVID-19 can send their details.

Job openings for Pharmacy Graduates (23 posts) at BPPI | Salary upto Rs. 2,00,000 pm

Applications are invited for Pharmacists (04 posts) under NHM

Applications are invited from the candidates for post of Pharmacist under National Health Mission.

Post : Pharmacist

Work as Technicians - Thermographers at Niramai Health Analytix | 05 posts

NIRAMAI, are developing a novel software to detect breast cancer at a much earlier stage than traditional methods or self-examination. The core technology of our solution is an artificial intelligence led diagnostic platform that uses patented thermal image processing and machine learning algorithms for reliable and accurate breast cancer screening. This unique solution can be used as a cancer diagnosis test in hospitals, used for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.

Post : Technicians - Thermographers (05 Posts)

U.S. Food and Drug Administration issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problems, that have been reported with their use for the treatment or prevention of COVID-19, for which they are not approved by the FDA. These risks, which are in the drug labels for their approved uses, may be mitigated when health care professionals closely screen and supervise these patients such as in a hospital setting or a clinical trial, as indicated in the Emergency Use Authorization (EUA) for these drugs to treat COVID-19.

Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe cases of ROP, which occur in a region of the retina known as posterior zone 1, as shown. David Wallace, M.D.

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently. Results from the dose-finding study were published April 23 in JAMA Ophthalmology. The study was conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and supported by the National Eye Institute (NEI), part of the National Institutes of Health.

The U.S. Food and Drug Administration has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). This action is a continuation of the FDA’s efforts to pursue companies that illegally market CBD products with claims that they can treat medical conditions, including opioid addiction or as an alternative to opioids.